Rosalyn Miles
Neurology · Clayton, MONPI 1811190093
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,307 of the $6,318 with a category attached, or 84.0%. It is spread thinly across 37 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. 2022 is the largest year on record at $2,936, 2.5 times the $1,164 reported in 2019.
Across 311 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$1K
- Livanova USA, Inc.$1K
- UCB, Inc.$513
- AbbVie$313
- Amgen$291
- Amneal Pharmaceuticals LLC$240
- plus $3K from 31 others
What the payments were for
- Speaking & faculty fees$1432%
- Travel & lodging$81113%
- Food & beverage$5,30784%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 79 | $1,215 |
| Livanova USA, Inc. | 5 | $1,132 |
| UCB, Inc. | 32 | $513 |
| AbbVie(2 entities) | 20 | $313 |
| Amgen | 16 | $291 |
| Amneal Pharmaceuticals LLC | 17 | $240 |
| Sanofi | 13 | $228 |
| Bristol Myers Squibb | 15 | $199 |
| Teva Pharmaceuticals USA, Inc. | 10 | $187 |
| Novartis | 11 | $179 |
| EMD Serono, Inc. | 13 | $166 |
| GRT US Holding, Inc. | 3 | $151 |
| Acadia Pharmaceuticals Inc | 10 | $150 |
| Acorda Therapeutics, Inc | 1 | $143 |
| Lilly USA, LLC | 9 | $143 |
| Banner Life Sciences, LLC | 9 | $142 |
| Jazz Pharmaceuticals Inc. | 6 | $133 |
| Johnson & Johnson | 5 | $89 |
| Kyowa Kirin, Inc. | 5 | $78 |
| SK Life Science, Inc. | 3 | $69 |
| MDD US Operations, LLC | 3 | $63 |
| Neurocrine Biosciences, Inc. | 3 | $58 |
| Greenwich Biosciences, Inc. | 2 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $47 |
| Lundbeck LLC | 2 | $37 |
| Eisai Inc. | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $35 |
| Portola Pharmaceuticals, LLC | 2 | $34 |
| AstraZeneca | 2 | $29 |
| Neurelis, Inc. | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 2 | $25 |
| Medtronic | 1 | $23 |
| Catalyst Pharmaceuticals, Inc. | 1 | $21 |
| CSL Behring | 1 | $19 |
| Urovant Sciences Inc | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS - Sentiva$1,001
- INBRIJA$143
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$131
- Qutenza$120
How this compares
$6,318 in reported general payments places this provider in the 75th percentile of 381 neurology providers in Missouri.
Other neurology in Clayton
- William RosenfeldChesterfield$2.1M
- Barry SingerSaint Louis$1.9M
- Mark TullmanSaint Louis$1.5M
- Curtis SchreiberBolivar$882K
- Robert NaismithSaint Louis$677K
- Daniel MattsonBridgeton$451K
- Siddharth KaulBridgeton$387K
- Barbara GreenChesterfield$352K
- Steven KosaNorth Kansas City$323K
- Seth HepnerBridgeton$285K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.